A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
The global sales of DNA polymerase are estimated to be worth USD 397.7 million in 2025 and anticipated to reach a value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback